FDA Approves Merck Drug To Reverse Effects Of Muscle Relaxants
Merck & Co Inc.'s drug to reverse the effects of muscle relaxants used during surgery has won U.S. approval.The Food and Drug Administration said...
Acetaminophen May Do No Good For Flu
Acetaminophen may not have an effect on the flu virus or its symptoms, according to a new study.International guidelines, including those of the British...
Some Topical Anti-Inflammatory Drugs Can Rival Oral Versions
The Ache: Oral nonsteroidal anti-inflammatory drugs, or NSAIDs, are widely used to reduce pain and swelling from arthritis and sprains and strains, but they...
Another American Ebola Survivor Had Eye Problems
Ebola survivor Dr. Ian Crozier wasn't the only American to experience eye problems following the disease — a new report describes eye problems in...
FDA Approves Takeda Drug For Blood Cancer Multiple Myeloma
The U.S. Food and Drug Administration on Friday approved a third drug to treatmultiple myeloma, a type of blood cancer.
The approved pill, called Ninlaro,...
Antibiotic Resistance: World On Cusp Of ‘Post-Antibiotic Era’
The world is on the cusp of a "post-antibiotic era", scientists have warned after finding bacteria resistant to drugs used when all other treatments...
Pill Protects Against HIV in Real-World Settings
A once-a-day pill for preventing infection with the human immunodeficiency virus (HIV), the virus that causes AIDS, has been effective in clinical trials, and...
Crucial Things You Should Know About Addiction
There is one thing killing people all over the world. It is one of the biggest killers ever, yet no one wants to talk...
Americans Are Using More Prescription Drugs Than Ever Before
Americans are taking more prescription drugs than ever before, according to a new study that finds almost three in five take at least one...
Novartis, Juno Face Production Hurdles For New Blood Cancer Drugs
As drugmakers including Novartis, Juno Therapeutics and Kite Pharma race to launch what may be the most effective treatments ever seen for leukemia and...